APC 366 tryptase inhibitor: Began Phase Ib trial in 30 patients of multiple doses of up to 5 mg three times daily, over four days. The drug will be given by inh

Arris Pharmaceutical Corp. (ARRS), South

Read the full 53 word article

How to gain access

Continue reading with a
two-week free trial.